Hereditary Haemorrhagic Telangiectasia, an Inherited Vascular Disorder in Need of Improved Evidence-Based Pharmaceutical Interventions
出版年份 2021 全文链接
标题
Hereditary Haemorrhagic Telangiectasia, an Inherited Vascular Disorder in Need of Improved Evidence-Based Pharmaceutical Interventions
作者
关键词
-
出版物
Genes
Volume 12, Issue 2, Pages 174
出版商
MDPI AG
发表日期
2021-01-27
DOI
10.3390/genes12020174
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Molecular basis of ALK1-mediated signalling by BMP9/BMP10 and their prodomain-bound forms
- (2020) Richard M. Salmon et al. Nature Communications
- Efficacy and Safety of a 0.1% Tacrolimus Nasal Ointment as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Double-Blind, Randomized, Placebo-Controlled, Multicenter Trial
- (2020) Sophie Dupuis-Girod et al. Journal of Clinical Medicine
- BMP-SMAD1/5 Signaling Regulates Retinal Vascular Development
- (2020) Andreas Benn et al. Biomolecules
- Somatic Gain of KRAS Function in the Endothelium is Sufficient to Cause Vascular Malformations that Require MEK but not PI3K Signaling
- (2020) Jason E Fish et al. CIRCULATION RESEARCH
- Overexpression of Activin Receptor-Like Kinase 1 in Endothelial Cells Suppresses Development of Arteriovenous Malformations in Mouse Models Of Hereditary Hemorrhagic Telangiectasia
- (2020) Yong Hwan Kim et al. CIRCULATION RESEARCH
- An international, multicenter study of intravenous bevacizumab for bleeding in hereditary hemorrhagic telangiectasia: the InHIBIT-Bleed study
- (2020) Hanny Al-Samkari et al. HAEMATOLOGICA
- Oncogenes in Brain Arteriovenous Malformations
- (2020) Lars Jakobsson et al. CIRCULATION RESEARCH
- Topical Propranolol Improves Epistaxis Control in Hereditary Hemorrhagic Telangiectasia (HHT): A Randomized Double-Blind Placebo-Controlled Trial
- (2020) Meir Mei-Zahav et al. Journal of Clinical Medicine
- Safety, Tolerability, and Management of Toxic Effects of Phosphatidylinositol 3-Kinase Inhibitor Treatment in Patients With Cancer
- (2019) Angela Esposito et al. JAMA Oncology
- Angiopoietin-2 Inhibition Rescues Arteriovenous Malformation in a Smad4 Hereditary Hemorrhagic Telangiectasia Mouse Model
- (2019) Angela M. Crist et al. CIRCULATION
- Role of soluble endoglin in BMP9 signaling
- (2019) Aleksandra Lawera et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PI3K (Phosphatidylinositol 3-Kinase) Activation and Endothelial Cell Proliferation in Patients with Hemorrhagic Hereditary Telangiectasia Type 1
- (2019) Adriana Iriarte et al. Cells
- Somatic Mutations in Vascular Malformations of Hereditary Hemorrhagic Telangiectasia Result in Bi-allelic Loss of ENG or ACVRL1
- (2019) Daniel A. Snellings et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Efficacy of TIMOLOL nasal spray as a treatment for epistaxis in hereditary hemorrhagic telangiectasia. A double-blind, randomized, placebo-controlled trial
- (2019) Sophie Dupuis-Girod et al. Scientific Reports
- BMP10-mediated ALK1 signaling is continuously required for vascular development and maintenance
- (2019) Teresa L. Capasso et al. ANGIOGENESIS
- Loss of Endothelial Endoglin Promotes High-Output Heart Failure Through Peripheral Arteriovenous Shunting Driven by VEGF Signaling
- (2019) Simon Tual-Chalot et al. CIRCULATION RESEARCH
- Correcting Smad1/5/8, mTOR, and VEGFR2 treats pathology in hereditary hemorrhagic telangiectasia models
- (2019) Santiago Ruiz et al. JOURNAL OF CLINICAL INVESTIGATION
- Vascular deficiency of Smad4 causes arteriovenous malformations: a mouse model of Hereditary Hemorrhagic Telangiectasia
- (2018) Angela M. Crist et al. ANGIOGENESIS
- ALK1 Loss Results in Vascular Hyperplasia in Mice and Humans Through PI3K ActivationHighlights
- (2018) Elisenda Alsina-Sanchís et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Endoglin interacts with VEGFR2 to promote angiogenesis
- (2018) Hongyu Tian et al. FASEB JOURNAL
- Exon-skipping advances for Duchenne muscular dystrophy
- (2018) Lucía Echevarría et al. HUMAN MOLECULAR GENETICS
- A heterodimer formed by bone morphogenetic protein 9 (BMP9) and BMP10 provides most BMP biological activity in plasma
- (2018) Emmanuelle Tillet et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Reductions in brain pericytes are associated with arteriovenous malformation vascular instability
- (2018) Ethan A. Winkler et al. JOURNAL OF NEUROSURGERY
- Somatic Activating KRAS Mutations in Arteriovenous Malformations of the Brain
- (2018) Sergey I. Nikolaev et al. NEW ENGLAND JOURNAL OF MEDICINE
- Thalidomide Reduces Hemorrhage of Brain Arteriovenous Malformations in a Mouse Model
- (2018) Wan Zhu et al. STROKE
- Pazopanib may reduce bleeding in hereditary hemorrhagic telangiectasia
- (2018) Marie E. Faughnan et al. ANGIOGENESIS
- The use of thalidomide therapy for refractory epistaxis in hereditary haemorrhagic telangiectasia: systematic review
- (2018) L Harrison et al. JOURNAL OF LARYNGOLOGY AND OTOLOGY
- Decreased Expression of Vascular Endothelial Growth Factor Receptor 1 Contributes to the Pathogenesis of Hereditary Hemorrhagic Telangiectasia Type 2
- (2018) Jérémy H. Thalgott et al. CIRCULATION
- Tacrolimus rescues the signaling and gene expression signature of endothelial ALK1 loss-of-function and improves HHT vascular pathology
- (2017) Santiago Ruiz et al. HUMAN MOLECULAR GENETICS
- Selective effects of oral antiangiogenic tyrosine kinase inhibitors on an animal model of hereditary hemorrhagic telangiectasia
- (2017) Y. H. Kim et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Endoglin prevents vascular malformation by regulating flow-induced cell migration and specification through VEGFR2 signalling
- (2017) Yi Jin et al. NATURE CELL BIOLOGY
- Structural Basis of the Human Endoglin-BMP9 Interaction: Insights into BMP Signaling and HHT1
- (2017) Takako Saito et al. Cell Reports
- Liver immunology and its role in inflammation and homeostasis
- (2016) Mark W Robinson et al. Cellular & Molecular Immunology
- Alk1 controls arterial endothelial cell migration in lumenized vessels
- (2016) Elizabeth R. Rochon et al. DEVELOPMENT
- Defective fluid shear stress mechanotransduction mediates hereditary hemorrhagic telangiectasia
- (2016) Nicolas Baeyens et al. JOURNAL OF CELL BIOLOGY
- PI3 kinase inhibition improves vascular malformations in mouse models of hereditary haemorrhagic telangiectasia
- (2016) Roxana Ola et al. Nature Communications
- A mouse model of hereditary hemorrhagic telangiectasia generated by transmammary-delivered immunoblocking of BMP9 and BMP10
- (2016) Santiago Ruiz et al. Scientific Reports
- Low-Dose FK506 (Tacrolimus) in End-Stage Pulmonary Arterial Hypertension
- (2015) Edda Spiekerkoetter et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Mouse models of hereditary hemorrhagic telangiectasia: recent advances and future challenges
- (2015) Simon Tual-Chalot et al. Frontiers in Genetics
- Hereditary hemorrhagic telangiectasia: genetics and molecular diagnostics in a new era
- (2015) Jamie McDonald et al. Frontiers in Genetics
- VEGF neutralization can prevent and normalize arteriovenous malformations in an animal model for hereditary hemorrhagic telangiectasia 2
- (2014) Chul Han et al. ANGIOGENESIS
- Therapeutics Based on Stop Codon Readthrough
- (2014) Kim M. Keeling et al. Annual Review of Genomics and Human Genetics
- Endothelial Depletion of Acvrl1 in Mice Leads to Arteriovenous Malformations Associated with Reduced Endoglin Expression
- (2014) Simon Tual-Chalot et al. PLoS One
- Genetic variants of Adam17 differentially regulate TGF signaling to modify vascular pathology in mice and humans
- (2014) K. Kawasaki et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- BMP9 Mutations Cause a Vascular-Anomaly Syndrome with Phenotypic Overlap with Hereditary Hemorrhagic Telangiectasia
- (2013) Whitney L. Wooderchak-Donahue et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Bone morphogenetic protein 9 (BMP9) controls lymphatic vessel maturation and valve formation
- (2013) S. Levet et al. BLOOD
- Circulating Bmp10 acts through endothelial Alk1 to mediate flow-dependent arterial quiescence
- (2013) D. W. Laux et al. DEVELOPMENT
- Context-dependent signaling defines roles of BMP9 and BMP10 in embryonic and postnatal development
- (2013) H. Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Reduced Mural Cell Coverage and Impaired Vessel Integrity After Angiogenic Stimulation in the Alk1 -deficient Brain
- (2012) Wanqiu Chen et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- BMP9 and BMP10 are critical for postnatal retinal vascular remodeling
- (2012) N. Ricard et al. BLOOD
- Bevacizumab in Patients With Hereditary Hemorrhagic Telangiectasia and Severe Hepatic Vascular Malformations and High Cardiac Output
- (2012) Sophie Dupuis-Girod et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Specificity and Structure of a High Affinity Activin Receptor-like Kinase 1 (ALK1) Signaling Complex
- (2012) Sharon A. Townson et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- BMP9 is produced by hepatocytes and circulates mainly in an active mature form complexed to its prodomain
- (2011) Marie Bidart et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Interaction between alk1 and blood flow in the development of arteriovenous malformations
- (2011) P. Corti et al. DEVELOPMENT
- Soluble Endoglin Specifically Binds Bone Morphogenetic Proteins 9 and 10 via Its Orphan Domain, Inhibits Blood Vessel Formation, and Suppresses Tumor Growth
- (2011) Roselyne Castonguay et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Immunosuppressor FK506 Increases Endoglin and Activin Receptor-Like Kinase 1 Expression and Modulates Transforming Growth Factor- 1 Signaling in Endothelial Cells
- (2011) V. Albinana et al. MOLECULAR PHARMACOLOGY
- Hereditary haemorrhagic telangiectasia: Pathophysiology, diagnosis and treatment
- (2010) Claire L. Shovlin BLOOD REVIEWS
- Pathogenesis of Arteriovenous Malformations in the Absence of Endoglin
- (2010) Marwa Mahmoud et al. CIRCULATION RESEARCH
- Reduced plasma levels of Ang-2 and sEng as novel biomarkers in hereditary hemorrhagic telangiectasia (HHT)
- (2010) Luisa Ojeda-Fernandez et al. CLINICA CHIMICA ACTA
- Hereditary hemorrhagic telangiectasia: from molecular biology to patient care
- (2010) S. DUPUIS-GIROD et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia
- (2010) Franck Lebrin et al. NATURE MEDICINE
- Expression of vascular endothelial growth factor is coordinately regulated by the activin-like kinase receptors 1 and 5 in endothelial cells
- (2009) E. S. Shao et al. BLOOD
- Real-time imaging of de novo arteriovenous malformation in a mouse model of hereditary hemorrhagic telangiectasia
- (2009) Sung Ok Park et al. JOURNAL OF CLINICAL INVESTIGATION
- Bone Morphogenetic Protein-9 Is a Circulating Vascular Quiescence Factor
- (2008) Laurent David et al. CIRCULATION RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now